FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Abstract

FMS-like tyrosine kinase III (FLT3) mutations occur in one-third of acute myeloid leukemia (AML) patients and predict poor outcome. The incidence and impact of FLT3 in myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) is unknown. We conducted a retrospective review to identify WHO MDS and CMML patients with FLT3 mutations at… (More)
DOI: 10.1002/ajh.23345

Topics

4 Figures and Tables

Cite this paper

@article{Daver2013FLT3MI, title={FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia.}, author={Naval G Daver and Paolo Strati and Elias J Jabbour and Tapan M Kadia and Raja Luthra and Sa Wang and Keyur Patel and Farhad Ravandi and Jorge Cort{\'e}s and Xiao Qin Dong and Hagop M. Kantarjian and Guillermo Garc{\'i}a-Manero}, journal={American journal of hematology}, year={2013}, volume={88 1}, pages={56-9} }